Publication
Treatment of Retinal Vein Occlusion with Ranibizumab in Clinical Practice: Longer-Term Results and Predictive Factors of Functional Outcome
| dc.contributor.author | Farinha, C | |
| dc.contributor.author | Marques, JP | |
| dc.contributor.author | Almeida, E | |
| dc.contributor.author | Baltar, A | |
| dc.contributor.author | Santos, AR | |
| dc.contributor.author | Melo, P | |
| dc.contributor.author | Costa, M | |
| dc.contributor.author | Figueira, J | |
| dc.contributor.author | Cachulo, ML | |
| dc.contributor.author | Pires, I | |
| dc.contributor.author | Silva, R | |
| dc.date.accessioned | 2019-07-03T14:17:17Z | |
| dc.date.available | 2019-07-03T14:17:17Z | |
| dc.date.issued | 2015 | |
| dc.description.abstract | To evaluate long-term results and predictors of efficacy in patients with macular edema due to retinal vein occlusion (RVO) treated with intravitreal ranibizumab in a clinical practice setting. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Ophthalmic Res. 2015;55(1):10-8. | pt_PT |
| dc.identifier.doi | 10.1159/000440848 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.4/2242 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.subject | Inibidores da Angiogénese | pt_PT |
| dc.subject | Ranibizumabe | pt_PT |
| dc.subject | Oclusão da Veia Retiniana | pt_PT |
| dc.subject | Humans | pt_PT |
| dc.subject | Middle Aged | pt_PT |
| dc.title | Treatment of Retinal Vein Occlusion with Ranibizumab in Clinical Practice: Longer-Term Results and Predictive Factors of Functional Outcome | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 18 | pt_PT |
| oaire.citation.issue | 1 | pt_PT |
| oaire.citation.startPage | 10-8 | pt_PT |
| oaire.citation.volume | 55 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |